Inogen (INGN) Cash & Current Investments (2013 - 2026)
Inogen's (INGN) quarterly Cash & Current Investments came in at $110.2 million in Q1 2026, down 10.09% year-on-year from $122.5 million in Q1 2025, and up 4.91% on a QoQ basis from $105.0 million in Q4 2025.
Inogen (INGN) Cash & Current Investments (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Cash & Current Investments data on file, last reported at $110.2 million in Q1 2026.
- On a quarterly basis, Cash & Current Investments fell 10.09% year-over-year to $110.2 million in Q1 2026; TTM through Mar 2026 was $110.2 million, a 10.09% decrease from a year earlier, with the FY2025 full-year figure at $105.0 million, down 13.23% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $110.2 million, up from $105.0 million in the prior quarter.
- Over the last five years, Cash & Current Investments for INGN reached as high as $223.4 million in Q1 2022 and fell as low as $34.8 million in Q2 2022.
- Historically, Cash & Current Investments has averaged $115.9 million across 5 years, with a median of $117.7 million in 2024.
- On a YoY basis, Cash & Current Investments climbed as much as 261.22% in 2022 and fell as far as 86.1% in 2022.
- Year by year, Cash & Current Investments stood at $206.0 million in 2022, then plunged by 37.62% to $128.5 million in 2023, then dropped by 5.79% to $121.0 million in 2024, then fell by 13.23% to $105.0 million in 2025, then advanced by 4.91% to $110.2 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $110.2 million in Q1 2026, $105.0 million in Q4 2025, and $107.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Inogen | 175.14 Mn | 64.97 Mn | 37.86 Mn | 110.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 110.17 Mn |
| Dec 31, 2025 | 105.02 Mn |
| Sep 30, 2025 | 107.76 Mn |
| Jun 30, 2025 | 122.43 Mn |
| Mar 31, 2025 | 122.54 Mn |
| Dec 31, 2024 | 121.04 Mn |
| Sep 30, 2024 | 109.28 Mn |
| Jun 30, 2024 | 117.69 Mn |
| Mar 31, 2024 | 119.81 Mn |
| Dec 31, 2023 | 128.47 Mn |
| Sep 30, 2023 | 37.17 Mn |
| Jun 30, 2023 | 47.61 Mn |
| Mar 31, 2023 | 38.78 Mn |
| Dec 31, 2022 | 205.95 Mn |
| Sep 30, 2022 | 218.11 Mn |
| Jun 30, 2022 | 34.76 Mn |
| Mar 31, 2022 | 223.39 Mn |
| Dec 31, 2021 | 245.51 Mn |
| Sep 30, 2021 | 245.13 Mn |
| Jun 30, 2021 | 249.96 Mn |